Malignant pleural mesothelioma. Multivariate analysis of prognostic factors on 113 patients
- PMID: 8317897
Malignant pleural mesothelioma. Multivariate analysis of prognostic factors on 113 patients
Abstract
We report on clinical features of 113 cases of pathologically confirmed Malignant Pleural Mesothelioma, observed in Genoa (Italy) between 1979 and 1985. Overall median survival was 10 months. Among the pretreatment variables studied (age, sex, asbestos exposure, pathological type, chest pain and dyspnea at the time of diagnosis), the only one of prognostic value in the univariate analysis was the histological subtype: median survivals were 12, 7 and 4 months for the patients in the epithelial, mixed, and fibrosarcomatous groups, respectively (p = 0.0012). A multivariate analysis confirmed the independent predictive power of the histotype (p = 0.0022). A review of literature data concerning prognostic factors in Malignant Pleural Mesothelioma is presented.
Similar articles
-
[Malignant mesothelioma in Basse-Normandie, a French population study. Descriptive analysis, prognostic factors and survival].Rev Epidemiol Sante Publique. 2001 Dec;49(6):523-9. Rev Epidemiol Sante Publique. 2001. PMID: 11845101 French.
-
[Malignant mesothelioma: study of prognostic factors in a series of 188 cases].Arch Anat Cytol Pathol. 1993;41(5-6):205-11. Arch Anat Cytol Pathol. 1993. PMID: 8135581 Review. French.
-
Malignant pleural mesothelioma: clinicopathologic and survival characteristics in a consecutive series of 394 patients.Eur J Cardiothorac Surg. 2008 Feb;33(2):307-13. doi: 10.1016/j.ejcts.2007.09.044. Eur J Cardiothorac Surg. 2008. PMID: 18164622
-
Treatment and survival in diffuse malignant pleural mesothelioma; a study of 83 cases from the Massachusetts General Hospital.Anticancer Res. 1996 May-Jun;16(3A):1265-8. Anticancer Res. 1996. PMID: 8702248
-
Diffuse malignant pleural mesotheslioma at CAMC: a retrospective study of 50 patients.W V Med J. 1997 May-Jun;93(3):120-5. W V Med J. 1997. PMID: 9197186 Review.
Cited by
-
Cell-growth and migration inhibition of human mesothelioma cells induced by 3-O-methylfunicone from Penicillium pinophilum and cisplatin.Invest New Drugs. 2012 Aug;30(4):1343-51. doi: 10.1007/s10637-011-9698-1. Epub 2011 Jun 9. Invest New Drugs. 2012. PMID: 21656164
-
Late cutaneous metastases to the face from malignant pleural mesothelioma: a case report and review of the literature.World J Surg Oncol. 2009 Nov 9;7:84. doi: 10.1186/1477-7819-7-84. World J Surg Oncol. 2009. PMID: 19900274 Free PMC article. Review.
-
Simultaneous tongue metastasis from malignant pleural mesothelioma: Case report and literature review.Thorac Cancer. 2020 Dec 1;12(3):391-6. doi: 10.1111/1759-7714.13769. Online ahead of print. Thorac Cancer. 2020. PMID: 33289348 Free PMC article.
-
Prognostic factors for malignant mesothelioma in 142 patients: validation of CALGB and EORTC prognostic scoring systems.Thorax. 2000 Sep;55(9):731-5. doi: 10.1136/thorax.55.9.731. Thorax. 2000. PMID: 10950889 Free PMC article.
-
Management of malignant pleural effusions.Drugs. 1998 Jan;55(1):47-58. doi: 10.2165/00003495-199855010-00004. Drugs. 1998. PMID: 9463789 Review.
MeSH terms
Substances
LinkOut - more resources
Medical